Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s ...

Access Vascular, Inc. (AVI), a leader in tackling critical vascular access challenges with its advanced hydrophilic biomaterial technology, today anno ...

The Magpies’ rich vein of form continued as they stretched their unbeaten run to nine games with this fourth successive victory.

During intensive and long-lasting treatments, short-term or emergency care, children often undergo minor needle-related ...

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.